Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Seres Therapeutics (MCRB)
NASDAQ:MCRB
Seres Therapeutics (MCRB) Stock Price & Analysis
660 Followers
MCRB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.50 - $9.49
Previous Close$4.87
Volume444.79K
Average Volume (3M)2.99M
Market Cap
$622.24M
Enterprise Value$679.05M
Total Cash (Recent Filing)$106.54M
Total Debt (Recent Filing)$162.71M
Price to Earnings (P/E)-2.1
Beta0.65
Next Earnings
Aug 01, 2023EPS Estimate
$0.52Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.31
Shares Outstanding127,901,391
10 Day Avg. Volume2,210,607
30 Day Avg. Volume2,993,013
Standard Deviation0.82
R-Squared0.03
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)-10.94
Price to Sales (P/S)-1193.26
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue132.81
Enterprise Value/Gross Profit95.26
Enterprise Value/Ebitda-2.68
Forecast
1Y Price Target
$10.17Price Target Upside109.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Seres Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MCRB FAQ
What was Seres Therapeutics’s price range in the past 12 months?
Seres Therapeutics lowest stock price was $2.50 and its highest was $9.49 in the past 12 months.
What is Seres Therapeutics’s market cap?
Currently, no data Available
When is Seres Therapeutics’s upcoming earnings report date?
Seres Therapeutics’s upcoming earnings report date is Aug 01, 2023 which is in 57 days.
How were Seres Therapeutics’s earnings last quarter?
Seres Therapeutics released its earnings results on May 09, 2023. The company reported -$0.57 earnings per share for the quarter, missing the consensus estimate of -$0.55 by -$0.02.
Is Seres Therapeutics overvalued?
According to Wall Street analysts Seres Therapeutics’s price is currently Undervalued.
Does Seres Therapeutics pay dividends?
Seres Therapeutics does not currently pay dividends.
What is Seres Therapeutics’s EPS estimate?
Seres Therapeutics’s EPS estimate is $0.52.
How many shares outstanding does Seres Therapeutics have?
Seres Therapeutics has 127,901,390 shares outstanding.
What happened to Seres Therapeutics’s price movement after its last earnings report?
Seres Therapeutics reported an EPS of -$0.57 in its last earnings report, missing expectations of -$0.55. Following the earnings report the stock price went up 0.18%.
Which hedge fund is a major shareholder of Seres Therapeutics?
Among the largest hedge funds holding Seres Therapeutics’s share is Flagship Pioneering Inc.. It holds Seres Therapeutics’s shares valued at 131M.
---
Seres Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.17 (109.04% Upside)
$10.17 (109.04% Upside)
Blogger Sentiment
Bullish
MCRB Sentiment 66%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 2.7%
Last 30 Days ▲ 2.7%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
52.66%
12-Months-Change
Fundamentals
Return on Equity
-1600.16%
Trailing 12-Months
Asset Growth
-15.53%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Seres Therapeutics
Seres Therapeutics, Inc. operates a microbiome therapeutics platform company, which engages in the development of biological drugs. The firm creates medicines using live bacteria to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. It focuses on implementing microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. The company was founded by Geoffrey von Maltzahn, David A. Berry and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding MCRB
Vanguard Total Stock Market ETF
$14.46M
iShares Biotechnology ETF
$3.40M
Vanguard Health Care ETF
$1.69M
iShares Core S&P Total U.S. Stock Market ETF
$463.37K
Middlefield Healthcare Dividend ETF Registered
$341.45K
Up to five ETFs with an Outperform Smart Score that hold MCRB. The ETFs are listed according to market value of MCRB within the ETF
---
---